Results 171 to 180 of about 25,460 (223)

Detrusor Overactivity with Detrusor Underactivity

2021
Detrusor Overactivity with Detrusor underactivity (formerly known as detrusor hyperactivity with impaired contractility) can often represent a diagnostic and therapeutic conundrum for urologists. Patients can present with a combination of symptoms, and the diagnosis is highly dependent on urodynamics, which can be difficult in the elderly population ...
Jessica J. Rueb, Howard B. Goldman
openaire   +1 more source

Early Effect on the Overactive Bladder Symptoms Following Botulinum Neurotoxin Type A Injections for Detrusor Overactivity

European Urology, 2008
Limited studies to date have reported on the onset of effect of intradetrusor botulinum neurotoxin type A (BoNTA) injections when used to treat the symptoms of the overactive bladder (OAB).
Sohier Elneil, Apostolos Apostolidis
exaly   +2 more sources

Overactive detrusor

Current Opinion in Urology, 1999
Detrusor overactivity poses a major challenge to physicians from many specialities. Progress in our understanding of the pathogenesis of detrusor overactivity is slow but steady. Advances in treatment continue to be made, both with new agents and new methods of delivering older drugs.
J, Sullivan, P, Abrams
openaire   +2 more sources

Oxybutynin in Detrusor Overactivity

Urologic Clinics of North America, 2006
Oxybutynin has been used for the management of detrusor overactivity for over 30 years and has withstood medical scrutiny and the test of time throughout the world. Although several agents in the class of bladder relaxants have only recently been studied, oxybutynin's effectiveness in reducing urinary frequency and urge urinary incontinence is ...
Ananias, Diokno, Michael, Ingber
openaire   +2 more sources

Surgery for detrusor overactivity

World Journal of Urology, 1998
Intractable detrusor overactivity can result in considerable morbidity and, in the case of neurogenic bladder dysfunction, can put the upper tracts at risk. Once conservative treatments have been exhausted the aim of surgery is to increase functional bladder capacity and decrease the maximal detrusor pressure at this capacity.
C R, Chapple, N P, Bryan
openaire   +2 more sources

Bryophyllum pinnatum Inhibits Detrusor Contractility in Porcine Bladder Strips—A Pharmacological Study Towards a New Treatment Option of Overactive Bladder

Phytomedicine, 2012
AIMS: A broad spectrum of synthetic agents is available for the treatment of overactive bladder. Anti-cholinergic drugs show a poor compliance due to side effects. There is an increasing use of plant extracts in medicine.
Daniel Eberli, Cornelia Betschart, R Brenneisen   +2 more
exaly   +2 more sources

Detrusor overactivity: an overview

Archives of Gynecology and Obstetrics, 2010
Detrusor overactivity (DO) is a common clinical problem having profound effects on the quality of life (QOL) of women. With the use of meshes in the antiincontinence surgery, a new onset of DO, de novo DO has become an important issue in postoperative QOL of women.
Kiran, Ashok, Alex, Wang
openaire   +2 more sources

Detrusor overactivity

Neurourology and Urodynamics, 1988
AbstractDetrusor pressure is only a partial reflection of bladder wall force. In order to better standardize the results of clinical studies, bladder wall activity has to be taken into account by relating detrusor pressures to volume levels.The 15 cm H2O threshold level is misleading.
Bo L. R. A. Coolsaet, Mostafa M. Elhilali   +1 more
openaire   +1 more source

Inhibition of Porcine Detrusor Contractility by the Flavonoid Fraction of Bryophyllum pinnatum – A Potential Phytotherapeutic Drug for the Treatment of the Overactive Bladder Syndrome

Phytomedicine, 2015
AIMS: To determine if the phytotherapeutic agent, Bryophyllum pinnatum, could serve as an alternative drug for the overactive bladder syndrome, and to characterise the fraction responsible for the inhibition of detrusor contractility. METHODS: Fractions
Daniel Eberli, Cornelia Betschart, R Brenneisen   +2 more
exaly   +2 more sources

Pharmacotherapy for Neurogenic Detrusor Overactivity

American Journal of Physical Medicine & Rehabilitation, 2006
Chancellor MB, Anderson RU, Boone TB: Pharmacotherapy for neurogenic detrusor overactivity. Am J Phys Med Rehabil 2006;85:536-545. Patients with neurogenic detrusor overactivity are a heterogeneous group with voiding dysfunction secondary to neurologic injury or disease. The neurogenic detrusor overactivity syndrome, which may include urinary frequency,
Michael B, Chancellor, Rodney U, Anderson, Timothy B, Boone   +2 more
openaire   +2 more sources